Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Thymalfasin for Injection

Approval Number

国药准字H20223429

Company天津红日药业股份有限公司

Registration Date

June 28, 2022

Drug Information

Generic Name

注射用胸腺法新

Dosage Form

注射剂

Strength

1.6mg

Drug Type

化学药品

Registration Date

June 28, 2022

Company Information

Applicant Company

Company Name天津红日药业股份有限公司

Company Address

天津新技术产业园区武清开发区泉发路西

Manufacturing Company

Company Name天津红日药业股份有限公司

Company Address

天津新技术产业园区武清开发区源泉路17号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy